Citius Oncology (CTOR) Notes Payables (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Notes Payables of $3.8 million for Q1 2026, little changed year-over-year from $3.8 million in Q1 2025, and little changed quarter-over-quarter from $3.8 million in Q4 2025.
Citius Oncology (CTOR) Notes Payables (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Notes Payables for 4 consecutive years, with $3.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables changed 0.0% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (changed 0.0% YoY), while the FY2025 annual figure was $3.8 million, changed 0.0% from the prior year.
- Notes Payables was little changed at $3.8 million in Q1 2026 per CTOR's latest filing, from $3.8 million in the prior quarter.
- Across five years, Notes Payables topped out at $3.8 million in Q3 2024 and bottomed at $1.3 million in Q4 2023.
- Historically, Notes Payables has averaged $3.1 million across 4 years, with a median of $3.8 million in 2024.
- Annual changes were most pronounced in 2024 — Notes Payables jumped 187.89% — and 2025, when it changed 0.0%.
- Citius Oncology's Notes Payables stood at $1.3 million in 2023, then surged by 187.89% to $3.8 million in 2024, then changed by 0.0% to $3.8 million in 2025, then changed by 0.0% to $3.8 million in 2026.
- Business Quant data shows CTOR's Notes Payables at $3.8 million in Q1 2026, $3.8 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.87 Bn | 2.15 Bn |
| 3 | Zoetis | 32.47 Bn | 30.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.38 Bn | 19.71 Bn | 683.80 Mn |
| 6 | Viatris | 18.85 Bn | 17.96 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.52 Bn | 15.13 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.90 Bn | 11.37 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Citius Oncology | 77.79 Mn | 77.79 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.80 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.80 Mn |
| Jun 30, 2025 | 3.80 Mn |
| Mar 31, 2025 | 3.80 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 1.32 Mn |